Peer-reviewed journal articles (26)
2.
Mignolet, M., Gilloteaux, J., Halloin, N., Gueibe, M., Willemart, K., De Swert, K., Bielarz, V., Suain, V., Pastushenko, I., Gillet, N., & Nicaise, C. (2023). Viral Entry Inhibitors Protect against SARS-CoV-2-Induced Neurite Shortening in Differentiated SH-SY5Y Cells. Viruses, 15(10), 2020. doi:10.3390/v151020203.
Gilloteaux, J., De Swert, K., Suain, V., Brion, J. P., & Nicaise, C. (2023). Loss of Ephaptic Contacts in the Murine Thalamus during Osmotic Demyelination Syndrome. Ultrastructural pathology, 47(5), 398-423. doi:10.1080/01913123.2023.22324524.
De Fisenne, M.-A., Yilmaz, Z., De Decker, R., Suain, V., Buée, L., Ando, K., Brion, J. P., & Leroy, K. (2022). Alzheimer PHF-tau aggregates do not spread tau pathology to the brain via the Retino-tectal projection after intraocular injection in male mouse models. Neurobiology of disease, 174, 105875. doi:10.1016/j.nbd.2022.1058755.
Ando, K., Ndjim, M., Turbant, S., Fontaine, G., Pregoni, G., Dauphinot, L., Yilmaz, Z., Suain, V., Mansour, S., Authelet, M., De Dekker, R., Leroy, K., Delatour, B., Letournel, F., Martin-Négrier, M.-L., Chapon, F., Godfraind, C., Maurage, C.-A., Deramecourt, V., Meyronnet, D., Streichenberger, N., De Paula Rosa Passetti, A. P., Rigau, V., & Burel-Vandenbos, F. (2020). The lipid phosphatase Synaptojanin 1 undergoes a significant alteration in expression and solubility and is associated with brain lesions in Alzheimer’s disease. Acta neuropathologica communications, 8(1). doi:10.1186/s40478-020-00954-16.
Ando, K., Ferlini, L., Suain, V., Yilmaz, Z., Mansour, S., Le Ber, I., Bouchard, C., Leroy, K., Durr, A., Clot, F., Sarazin, M., Bier, J. C., & Brion, J. P. (2020). de novo MAPT mutation G335A causes severe brain atrophy, 3R and 4R PHF-tau pathology and early onset frontotemporal dementia. Acta neuropathologica communications, 8(1), 94. doi:10.1186/s40478-020-00977-87.
Ando, K., De Decker, R., Vergara Panos, C., Yilmaz, Z., Mansour, S., Suain, V., Sleegers, K., De Fisenne, M.-A., Houben, S., Potier, M.-C., Duyckaerts, C., Watanabe, T., Buée, L., Leroy, K., & Brion, J. P. (2020). Picalm reduction exacerbates tau pathology in a murine tauopathy model. Acta Neuropathologica, 139(4), 773-789. doi:10.1007/s00401-020-02125-x8.
Dalla Valle, A., Vertongen, P., Spruyt, D., Lechanteur, J., Suain, V., Gaspard, N., Brion, J. P., Gangji, V., & Rasschaert, J. (2019). Induction of Stearoyl-CoA 9-Desaturase 1 Protects Human Mesenchymal Stromal Cells Against Palmitic Acid-Induced Lipotoxicity and Inflammation. Frontiers in endocrinology, 10, 726. doi:10.3389/fendo.2019.007269.
Poncelet, L., Ando, K., Vergara Panos, C., Mansour, S., Suain, V., Yilmaz, Z., Reygel, A., Gilissen, E., Brion, J. P., & Leroy, K. (2019). A 4R tauopathy develops without amyloid deposits in aged cat brains. Neurobiology of aging, 81, NBA10594, 200-212. doi:10.1016/j.neurobiolaging.2019.05.02410.
Bouchat, J., Gilloteaux, J., Suain, V., Van Vlaender, D., Brion, J. P., & Nicaise, C. (2019). Ultrastructural Analysis of Thalamus Damages in a Mouse Model of Osmotic-Induced Demyelination. Neurotoxicity research, 36(1), 144-162. doi:10.1007/s12640-019-00041-x11.
Vergara Panos, C., Houben, S., Suain, V., Yilmaz, Z., De Decker, R., Vanden Dries, V., Boom, A., Mansour, S., Leroy, K., Ando, K., & Brion, J. P. (2019). Amyloid-β pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo. Acta Neuropathologica, 137(3), 397-412. doi:10.1007/s00401-018-1953-512.
Vanden Dries, V., Stygelbout, V., Pierrot, N., Yilmaz, Z., Suain, V., De Decker, R., Buée, L., Octave, J. N., Brion, J. P., & Leroy, K. (2017). Amyloid precursor protein reduction enhances the formation of neurofibrillary tangles in a mutant tau transgenic mouse model. Neurobiology of aging. doi:10.1016/j.neurobiolaging.2017.03.031